HIV-Associated Malignancy Research Centers (HAMRCs)
Led by the National Cancer Institute Office of HIV and AIDS Malignancy, the HAMRCs initiative aims to 1) develop research capacity in LMICs with a significant burden of HIV-associated cancers; 2) support collaborations between U.S. investigators and LMIC investigators; 3) and foster the development of early career investigators from the U.S. and LMICs interested in conducting research in HIV-associated cancers. PAVILION is one of 13 current HAMRCs.
International Papillomavirus Society (IPVS)
The IPVS promotes worldwide exchange of ideas, knowledge, and research materials among basic, clinical and public health research professionals concerned with human and animal papillomaviruses and their associated diseases. Many PAVILION members attend the IPVS International Conferences.
AIDS Malignancy Consortium (AMC)
The AMC investigates new treatment and prevention interventions through clinical trials and studies the pathobiology of malignancies in people living with HIV both in the USA and internationally.
US-Latin American-Caribbean HIV/HPV-Cancer Prevention Clinical Trials Network (ULACNet)
Led by the National Cancer Institute, ULACNet focuses on developing evidence to improve and optimize approaches for prevention of human papillomavirus (HPV)-related cancers in people living with human immunodeficiency virus (HIV) infection.
HIV/Cervical Cancer Prevention ‘CASCADE’ Clinical Trials Network
Led by the National Cancer Center Division of Cancer Prevention, the CASCADE Clinical Trials Network is a cooperative agreement-funded program focused on pragmatic clinical trials to optimize the cervical cancer screening, management, and precancer treatment cascade for women living with HIV.